Growth Investment Partners (GIP) Ghana Ltd, an investment platform established by British International Investment (BII), has announced a strategic investment in mPharma Ghana Ltd, a patient-centred ...
2don MSN
Corcept anticipates $3B–$5B annual hypercortisolism revenue with relacorilant as FDA decisions near
Management expects relacorilant’s approval for hypercortisolism and ovarian cancer to significantly accelerate growth, with projections of $3–$5 billion in annual revenue for hypercortisolism alone, ...
Ghana Ltd, an investment platform established by British International Investment (BII), has announced a strategic investment ...
Ghana Ltd, an investment platform established by British International Investment (BII), has announced a strategic investment in mPharma Ghana Ltd, a patient-centred and technology-driven healthcare ...
Move follows Globe reporting on closed preferred pharmacy networks that restrict where patients can buy medication ...
FillPoint Health, a Lyceum Health company and URAC/ACHC-accredited specialty pharmacy and MSO, announced today a strategic partnership with Noble, an Aptar Pharma company and global leader in drug ...
With the recent news of pharmacy closures as a result of Rite Aid’s bankruptcy, a local independent pharmacist is going ...
A government-granted monopoly has allowed a pharmacy benefit manager owned by Cigna to overbill the Defense Department for years, in what amounts to an enormous cash transfer from American taxpayers ...
Q3 2025 Earnings Call Transcript November 4, 2025 Corcept Therapeutics Incorporated misses on earnings expectations. Reported ...
The Centre for Global Allied Health and Centre for Global Pharmacy will advance global health collaboration and capacity ...
Cencora plans supply chain expansion with $1 billion investment to open new U.S. distribution centers by 2027 and 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback